Bill and Melinda Gates Foundation donations made to International AIDS Vaccine Initiative (IAVI)

This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of December 2019. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.

Table of contents

Basic donor information

ItemValue
Country United States
Wikipedia pagehttps://en.wikipedia.org/wiki/Bill_%26_Melinda_Gates_Foundation
Best overview URLhttps://en.wikipedia.org/wiki/Bill_%26_Melinda_Gates_Foundation
Facebook username gatesfoundation
LinkedIn username bill-&-melinda-gates-foundation
Websitehttps://www.gatesfoundation.org/
Donations URLhttps://www.gatesfoundation.org/How-We-Work/Quick-Links/Grants-Database
Twitter usernamegatesfoundation
Page on philosophy informing donationshttps://www.gatesfoundation.org/What-We-Do
Grant application process pagehttps://www.gatesfoundation.org/How-We-Work/General-Information/Grantseeker-FAQ
Regularity with which donor updates donations datacontinuous updates
Regularity with which Donations List Website updates donations data (after donor update)irregular
Lag with which donor updates donations datamonths
Lag with which Donations List Website updates donations data (after donor update)years
Data entry method on Donations List WebsiteSQL insertion commands generated by script https://github.com/riceissa/gates-foundation-iati-processing

Brief history: The Gates Foundation launched in 2000, with precursors starting in the 1990s, financed by the personal wealth of co-founder Bill Gates from Microsoft. Starting 2005, it scaled up its giving significantly after a large funding commitment from Warren Buffett

Brief notes on broad donor philosophy and major focus areas: See https://www.gatesfoundation.org/Who-We-Are/General-Information/Foundation-Factsheet for the grantmaking areas. The four grantmaking areas are the Global Development Program, Global Health Program, Global Policy and Advocacy, and United States Program. Within the United States Program the focus is on K-12 education, the Internet, and emergency relief

Notes on grant publication logistics: Although the Gates Foundation has a grants database on its website, as well as individual grant pages for every grant, we use the IATI data instead, because it can be processed programmatically (the data on the site does not allow for full data download or easy programmatic processing). This leads to a few problems: first, IATI data does not include grants made in the United States, since it focuses on development assistance (DA) spending. Second, IATI data is updated more infrequently. Third, it may sometimes omit some information that is present in the grants database

Full donor page for donor Bill and Melinda Gates Foundation

Basic donee information

We do not have any donee information for the donee International AIDS Vaccine Initiative (IAVI) in our system.

Full donee page for donee International AIDS Vaccine Initiative (IAVI)

Donor–donee relationship

Item Value

Donor–donee donation statistics

Cause areaCountMedianMeanMinimum10th percentile 20th percentile 30th percentile 40th percentile 50th percentile 60th percentile 70th percentile 80th percentile 90th percentile Maximum
Overall 22 2,793,404 9,624,259 -14,106,495 50,000 165,343 1,000,000 1,199,081 2,793,404 5,881,540 12,752,708 23,730,244 29,424,936 49,903,728
Global health 22 2,793,404 9,624,259 -14,106,495 50,000 165,343 1,000,000 1,199,081 2,793,404 5,881,540 12,752,708 23,730,244 29,424,936 49,903,728

Donation amounts by cause area and year

If you hover over a cell for a given cause area and year, you will get a tooltip with the number of donees and the number of donations.

Note: Cause area classification used here may not match that used by donor for all cases.

Cause area Number of donations Total 2018 2017 2016 2015 2014 2013 2012 2011 2007 2006
Global health (filter this donor) 22 211,733,696.00 -14,844,981.00 30,733,149.00 88,592,655.00 2,000,000.00 2,199,081.00 62,656,436.00 4,000,000.00 7,543,362.00 5,073,750.00 23,780,244.00
Total 22 211,733,696.00 -14,844,981.00 30,733,149.00 88,592,655.00 2,000,000.00 2,199,081.00 62,656,436.00 4,000,000.00 7,543,362.00 5,073,750.00 23,780,244.00

Graph of spending by cause area and year (incremental, not cumulative)

Graph of spending should have loaded here

Graph of spending by cause area and year (cumulative)

Graph of spending should have loaded here

Full list of donations in reverse chronological order (22 donations)

Amount (current USD)Amount rank (out of 22)Donation dateCause areaURLInfluencerNotes
-738,486.00212018-12-27Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to support an independent preclinical efficacy study and continued analysis of a promising experimental HIV vaccine with significant potential to advance into human clinical testing; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
-14,106,495.00222018-12-27Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to advance development and conduct a phase 1 clinical trial with VSV G-Env.BG505, a new HIV Env vaccine based on a novel live chimeric virus; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
2,793,404.00122017-10-25Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to provide general operating support for HIV vaccine research and product development capacity at IAVI’s Design and Development Laboratory; Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified.
27,774,402.0042017-10-13Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to support the preparation of clinical materials, execution of toxicology studies and data analyses for CAVD investigators towards development of an HIV/AIDS vaccine; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
165,343.00182017-08-09Global health/Health policy and administrative managementhttps://iatiregistry.org/publisher/bmgf-- to develop on behalf of the Global Health Clinical Consortium a training program for study coordinators working on clinical trials addressing major public health concerns in Lower-Middle-Income Country (LMIC) settings; Aid type: Other technical assistance. Affected regions: Africa.
1,000,000.00152016-11-29Global health/Health policy and administrative managementhttps://iatiregistry.org/publisher/bmgf-- to foster exploration and innovation needed to identify, develop and deliver the right global health products to those most in need; Aid type: Contributions to specific-purpose programmes and funds managed by implementing partners. Affected regions: Developing countries, unspecified.
21,869,468.0062016-10-13Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to advance development and conduct a phase 1 clinical trial with VSV G-Env.BG505, a new HIV Env vaccine based on a novel live chimeric virus; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
29,424,936.0032016-08-11Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to advance the CAVD-supported projects through the translational stage and into clinical evaluation, ultimately resulting in successful new HIV/AIDS interventions; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
578,711.00172016-07-12Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to facilitate communications and interactions among the parties composing the CAVD, in the belief that collaborative approaches will accelerate the discovery and development of an HIV vaccine; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
29,838,000.0022016-04-26Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to support the preparation of clinical materials, execution of toxicology studies and data analyses for CAVD investigators towards development of an HIV/AIDS vaccine; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
5,881,540.0092016-03-10Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to support an independent preclinical efficacy study and continued analysis of a promising experimental HIV vaccine with significant potential to advance into human clinical testing; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
2,000,000.00132015-10-20Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to support the International AIDS Vaccine Initiative for the Design and Development Lab; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
1,199,081.00142014-11-11Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to sustain and increase political support and financing for HIV vaccine research and development from European Union institutions and key Member States to help accelerate product development by ensuring a robust pipeline of vaccine candidates; Aid type: Contributions to specific-purpose programmes and funds managed by implementing partners. Affected regions: South of Sahara.
1,000,000.00152014-05-08Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- To foster exploration and innovation needed to identify, develop and deliver the right global health products to those most in need.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
12,752,708.0072013-11-05Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to provide core services across the HIV vaccine development process. Vaccine Product Development Center. Investment start date: 11/5/2013 to end date: 8/30/2016. Grantee name: International AIDS Vaccine Initiative (IAVI); Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
49,903,728.0012013-11-05Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to demonstrate that an HIV ENV based immunogen(s) can be designed to elicit bnAbs in humans and has the potential to prevent HIV infection.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
4,000,000.00112012-10-25Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to provide general operating support. IAVI General Operating Support Grant. Investment start date: 10/25/2012 to end date: 10/31/2013. Grantee name: International AIDS Vaccine Initiative (IAVI); Aid type: Core support to NGOs, other private bodies, PPPs and research institutes. Affected regions: Developing countries, unspecified.
7,543,362.0082011-11-07Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to advance two novel replicating HIV vaccines through clinical development. HIV Vaccine Clinical Candidates based on Replication-Competent Viral Vectors that Preferentially Replicate in Lymphoid Tissues. Investment start date: 11/7/2011 to end date: 10/31; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
73,750.00192007-10-19Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to enhance global awareness and visibility of AIDS vaccine research and development in developing countries among the general public and decisionmakers; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
5,000,000.00102007-08-02Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to establish a program to search for new innovative, potentially high risk, ideas/technologies that may offer promise to the HIV vaccine research and development field; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
50,000.00202006-10-24Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to fund a conference called Stop Cervical Cancer: Accelerating Global Access to HPV Vaccines; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
23,730,244.0052006-06-21Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to design, test and develop safe, effective and affordable novel HIV/AIDS vacccine candidates that elicit potent, durable and protective T cell responses; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.